干细胞之家 - 中国干细胞行业门户第一站

标题: 干细胞移植常用生物学词汇 [打印本页]

作者: fellc    时间: 2008-12-27 14:20     标题: 干细胞移植常用生物学词汇

2,3-DPG:2,3-diphosphatidylglyceric acid,2,3-二磷酸甘油酸
/ I8 y+ T1 F' j) O% H2-CdA:2-chlorodeoxyadenosin,cladribine,2-氯去氧腺苷
7 K1 I: F$ X3 b$ y0 |3H-TdR:tritiated thymide,氚标记胸腺嘧啶核苷
# j: K" s4 a5 g, r' I5-Aza:5-azacytidine,5-氮(杂)胞苷4 a8 A; C; u+ l0 S' K& n7 T
a2-PI:a2-antiplasmin, a2-纤溶酶原抑制物
+ F, M( k' o  d5 k; TAA:aplastic anemia,再生障碍性贫血
- ?5 C: T2 Z# x1 h0 Z) u4 TAAV:adeno-associated virus,腺病毒相关病毒
7 y3 p, W* |, T; H% _: @Ab:antibody,抗体
$ G6 N( ?8 a5 wABC:avidin-biiotin complex method, 亲和素生物素复合物法, b; l1 v7 @1 h* l" N- s# z! R
ABMT:autologous bone marrow transplant,自体骨髓移植- x9 x( h: F5 P' E5 G
Ac:accessory cell,辅佐细胞
& }! D9 l/ n2 P* gACD:acid citrate dextrose,酸性枸橼酸盐葡萄糖
+ m, B1 F" e0 IACP:acid phosphatase,酸性磷酸梅
- C9 j' ?3 r1 g6 hACTD:actinomycin D,放线菌素D9 ?" x; }' O9 @# ^
Acute:急性的
3 N8 ]7 F) p8 Q( p4 J% p. {ACV:cyclovir,阿昔洛韦1 l- z. J. m9 W+ r" l7 {
Ad:adenovirus,腺病毒& i, t  }* m. K% I4 `. ^7 X
AD:antigen determinant,抗原决定簇. X+ Y8 f, C- ]$ j/ `1 l# p, m
ADA:adenosine deaminase,腺苷脱氨酶
' I( X% c! u: LADCC:antibody-dependent cell-mediated cytotoxicity)抗体依赖细胞介导性细胞毒性+ k  j/ U3 b. u# C0 o2 t! h% m8 p, ^
Adjuvant therapy:辅助治疗# H! T# \( O, w3 C9 ?  x* E, U0 q  E
AEL:acute erythrocytic leukemia,急性红白血病- r6 v; G7 q1 T5 v* k9 Y, s" s
AEoL:acute eosinophilic leukemia,急性嗜酸粒细胞白血病" I" X+ F' q  m: _4 r+ U% I
AFP:alpha fetoprotein,甲胎蛋白4 p! M- {# }$ `1 y& r
Ag:antigen,抗原
- ~" @! p3 L9 n+ a2 waGVHD:acute graft versus host disease,急性移植物抗宿主病6 r0 D) R3 q# w! w" r* \* i% B
Aid:anti-idiotype antibody,抗独特型抗体
" |* `- a, x$ M! ^6 I' n3 l5 KAidS:acquired immune deficiency syndrome,获得性免疫缺陷综合征
; }" Y' n* K9 ?% p! qAIF:apoptosis-inducing factor,凋亡诱导因子1 p! [+ g% E2 l0 s! h; a
AIHA:autoimmune hemolytic anemia,自身免疫性溶血性贫血
, |" x- [6 a$ j& hAL:acute leukemia, 急性白血病4 B: I5 I# \+ b; x
ALCL:anaplastic large cell lymphoma,退行性大细胞淋巴瘤
' @0 b( m: X7 ~ALG:antilymphocyte globulin, 抗淋巴细胞球蛋白
1 q$ s- ], u$ {9 Y$ \0 p4 [ALIP:abnormal localization of immature precursor,未成熟前体细胞异常定位# j. h5 B! q- d! Q" c( w* u$ |
ALL:acute lymphocytic leukemia,急性淋巴细胞白血病
4 o/ S8 c6 a3 }Allo-BMT:allogeneic bone marrow transplantation,异基因骨髓移植
+ ]2 B/ e$ T0 b4 y$ R, _- RAllo-PBSCT:allogeneic peripheral blood stem cell transplantation,异基因外周血干细胞移植3 [& X' V6 z: n, P
Allogeneic:异基因的
4 c6 O8 `/ X* l: P' d: b4 x( @6 SAllograft:异体移植物
" N# P5 @5 ^0 z0 R& t2 vAlopecia:脱发) O  o8 x6 E- E' `
ALP(AKP):Alkaline phosphatase,碱性磷酸酶7 w3 d1 U6 V; r+ J
AM:adhesion molecule,粘附分子8 X0 `- D2 a# V! E6 s
AMKL:acute megakaryoblastic leukemia,急性巨核细胞白血病
! k1 P) n( t5 B, X! a( `0 K, BAML:acute myeloid leukemia,急性髓性白血病/ S2 Y% D% m, _4 E; z
AMM:agnogenic myeloid metaplasia,特发性髓外化生
/ i4 M8 V5 K- t; F9 i: m/ kANA:antinuclear antibody,抗核抗体
% @5 z' R( f3 y+ JAna-LL:anaplastic large cell lymphoma,大细胞淋巴瘤
0 W7 _" D6 w) _  Q% bAnaphylaxis:过敏症
+ r8 F# G. B3 m) f$ Q& f- t. W, E, Y' W) ?9 ]: g  z1 N
ANC:absolute neutrophil count,中性粒细胞绝对值* D6 H' o& ~) N/ E4 P, G# D. {* G  d
Anemia:贫血" r- r* {0 I; [8 r) S- C
ANLL:acute non-lymphocytic leukemia,急性非淋巴细胞性白血病6 R& m; N) q' q4 {/ T, t7 i1 L! f
Antibiotic:抗生素;抗生的
+ h& e1 n% N, j2 K& Q: m& B1 |/ L- lAntiemetic:止吐剂,止吐药 ' m# d0 u: a% \+ j9 K; _
antineoplastic drugs:抗肿瘤药物+ p( B1 p0 i& k/ A9 L& D2 }% j
Antisense:反义引物5 U# h* Y3 M) W  ?5 T
APBSCT:autologous peripheral blood stem cell transplantation,自体外周血干细胞移植' |2 o& R5 `; L) x( Q
APC:antigen processing cell,抗原呈递细胞# y" A1 K; S0 |# D! a% H  e
Apheresis:血浆分离置换法,血液成分部分清除
& C& }; N# Q$ G; ?: FAPL:acute promyelocytic leukemia,急性早幼粒细胞白血病
8 B# a; p7 g' p9 }- BAplasia:发育不良,成形不完全
/ \7 i9 p3 ]7 L1 bApoptosis:凋亡. M4 q- ]9 P7 X( T7 N' f6 c  K+ e
Ara-C:arabinosyl cytosine,aracytidine阿糖胞苷
9 A% j, \+ k- M) g# q; fARDS:acute respiratory distress syndrome,急性呼吸窘迫综合症;AidS-related diseases艾滋病相关疾病/ L, o" y3 X- T" m" g. C
Ascites:腹水
3 G# y8 Z  N! X4 bASCT:autologous stem cell transplantation,自体干细胞移植
' _, }( v* Z0 K$ z3 `7 ?4 lAspergillus:曲霉属
3 p- u9 h3 `9 t4 e3 f+ n" F$ tASS:anterior superior spine,髂前上棘
' E5 f, O7 C6 h: m' i4 iAT1257:nitrocaphane,消瘤芥7 U, i, c4 j* B; q4 G
ATG:antithymocyte globulin,抗胸腺细胞球蛋白
$ Z% ?( J) @$ z  ?ATL:adult T cell leukemia/lymphoma,成人T细胞白血病/淋巴瘤+ }; {; Q' n  j) W- }& m2 T/ G/ \
ATLS:acute tumor lysis syndrome,急性肿瘤溶解综合征1 J- T1 p3 k  C! Z
ATRA:all-transretinoic acid,全反式维甲酸7 f4 x7 H$ q" k5 Z# c
AUL:acute undifferentiated cell leukemia,急性未分化细胞白血病; R( H( s4 u( K! s9 \6 y* ]' k( k
AuSCT: autologous stem cell transplantation,自体造血干细胞移植! f7 X& R0 |* P# B) [& W8 C
Autologous:自体的
9 n. O7 ^5 m1 h, x+ bAutograft:自体移植物
, @; K: j! H- v5 tAuto-BMT: autologous bone marrow transplantation,自体骨髓移植
8 V* q: t9 ]$ ^! `- mβ2-MG:β2-microglobulin,β2-微球蛋白( W, g; ?/ p8 u, D2 A" G
Back-up:备份+ ~7 R5 m" P! {' o/ P9 m7 U
BCNU:Carmustine,卡氮芥,卡莫司汀
( G) r9 Y' D3 q+ VBCR:breakpoint cluster region,断裂点丛集区9 t  ], ?8 B' Z- U
BFU-E: burst-forming unit-erythroid,早期红系集落生成细胞/ A; {6 w  A/ J4 R4 g0 A# o
Biopsy:活检 4 g. s, A; c! x, _' c  d
Blast cell:原始血细胞,母细胞 5 k8 C6 y$ F' O
Blast-CFC:blast colony forming cell,原始细胞集落形成细胞
3 n+ q8 u9 W* n  i' P3 m, _Blast crisis:原始细胞危象 - G) i, g4 \- u; b3 J
Bm:memory B lymphocyte,记忆B淋巴细胞
/ J  Y& S+ ~' }6 X/ LBMG:benign monoclonal gammopathies,良性单克隆丙球蛋白病1 c" f- g* l, e8 c
BMT:bone marrow transplantation,骨髓移植
- a+ l/ ]" O9 j% ?. W& c( BBone marrow biopsy:骨髓活检
; r; X, \0 I/ Z1 d$ ABone marrow puncture:骨髓穿刺5 P5 ]+ Y, t' B0 ~: M
Bone marrow smear:骨髓穿刺涂片2 r& H. W6 d8 r2 w5 E2 ^9 N
BRM:biological response modifier,生物应答调节剂
' y( @9 Y  m" P: jBu:busulfan,白消安,马利兰
: C# A9 x6 ~- h# ]) K, a% W% n. DBuffer:缓冲,缓冲剂,缓冲液
# Y# Y. W& c- N1 f8 ^( V9 p' aCALLA:common acute lymphocytic leukemia antigen,普通急性淋巴细胞白血病抗原
( l, {1 S: `/ s& @% b7 VCAM:cell adhesion molecule,细胞粘附分子
7 X$ C1 c8 Z9 D$ F5 `5 P& rCandida:念珠菌属,假丝酵母属 6 ^7 Y, ^& ?2 q* m
Catheter:导管
; K5 n; W( r4 |+ ^CB:cord blood,脐带血
# j! ^7 W' n- M1 f: F/ hCB1348:chlorambucil:苯丁酸氮芥2 G3 x. l8 T' R& c. E
CBC:complete blood count,全血细胞计数 9 R9 [4 Q0 @# n4 A* a4 U
CBCL:cutaneous B-cell lymphoma,皮肤B细胞淋巴瘤
8 Z4 |" I: s3 _: V7 ]4 p% JCBSCT:cord blood stem cell transplantation,脐血干细胞移植
! [, h. @, S! Y( V) k- zCCI:corrected count increment,校正增值计数  A$ g& b3 U/ f3 t) N5 S. e! @+ O# D) Y
CCNSA:cell cycle non-specific agents,细胞周期非特异性药物 : G2 d- _% ~9 Q
CCNU:lomustine,洛莫司汀,环己亚硝脲
4 o2 h1 Q" `: ~  \. [" s# i4 ZCCR:continuous complete remission,持续完全缓解
- Y5 n5 t# B8 |/ j# S+ |$ HCCSA:cell cycle specific agents,细胞周期特异性药物
; x1 z: S" O2 w4 U6 K/ V( f& dCD:Castleman's disease,Castleman病6 i+ V+ \# x+ q3 m/ [+ ?. b( P
CD:cluster of differentiation,分化群5 T/ a9 C! Z$ j  P5 C
CD3AK:CD3 activated killer,CD3激活的杀伤细胞
; J1 @. T$ }3 Q2 sCDK:cyclin dependent protein kinase,周期素依赖蛋白激酶
9 M; M9 o4 c! \CEA:carcinoembryonic antigen,癌胚抗原
2 y) G* Z& G, Q1 C3 M' P( dCEL:chronic eosinophil leukemia,慢性嗜酸性粒细胞白血病
' o. O' F! f! R! dCentral line:中心静脉导管,见central venous catheter.
) I7 e5 B" J, i4 o% iCentral venous catheter: 中心静脉导管,又叫做central line,Hickman catheter ) b/ r9 D0 W$ T
Centrifugation:离心
" _* J/ m" H, }$ CCFC:colony-forming cell,克隆形成细胞
( m$ ^* t1 a9 M7 b: dCFU:colony-forming unit,集落形成单位
9 s4 Z" }  H; h; \% Z/ X% JCFU-Blast:colony-forming unit-Blast,原始集落生成细胞
! y. x" k% |  m, K- ^CFU-E:colony-forming unit-erythroid,红系集落生成细胞! k4 K: N2 m& \2 x! N( V
CFU-G:colony-forming unit-granulocyte,粒系集落生成细胞+ f' x1 F% O8 {( _; \1 ?
CFU-GM:colony-forming unit-granulocyte/macrophage,粒单系集落生成细胞
7 U7 }. i- G, f1 o. `0 o5 Y# a8 ^CFU-L:colony-forming unit-leukemia,白血病细胞集落生成单位
: b' ]+ W$ r% k  q2 hCFU-MEG:colony-forming unit-megakaryocyte巨核系集落生成细胞1 B4 ]( n' H. B: r% |  \) ^8 h* q
CGD:chronic granulomatous disease,慢性肉芽肿病
6 r5 A! T* o. o. yCGP:circulating granulocyte pool,循环粒细胞池0 `/ }! V( e2 `% f1 I* k
cGVHD:chronic graft versus host disease,慢性移植物抗宿主病1 Y  }$ f5 s, R. S, [$ }  L: A$ a# J
Chemo-responsive:化疗敏感的
3 G6 K4 O  {8 j9 T. `3 e2 PChemotherapy:化学疗法 + W; T" v+ ]: o# X0 e
Chronic慢性的 4 a" F7 f# {. K1 j2 z5 Y, S
C.I.:continuous infusion,持续静脉点滴
: \6 P. D& c5 w- S/ S5 ?CIK:cytokine-induced killer cells 细胞因子诱导的杀伤细胞8 W8 W  a) x4 j/ v
CliniMACS:clinical magnetic activated cell sorting,临床级磁性活化细胞分选系统6 N2 Q. s8 Q0 V6 D
CLL:chronic lymphocytic leukemia,慢性淋巴细胞白血病+ c1 B' C9 W- B& `# A* [* o; l- f
CML:chronic myelogenous leukemia,慢性粒细胞白血病
1 V. \+ T! T8 J+ c  Z# r1 F8 r; _CML-AP:CML-accelerated phase,慢性粒细胞白血病加速期
8 W0 ^/ ?2 p4 CCML-BP:CML-blastic phase,慢性粒细胞白血病急变期4 k. z0 w6 l- e2 A7 _4 \
CML-CP:CML-chronic phase,慢性粒细胞白血病慢性期
5 Z- L" j$ @- m% \  A. jCMML:chronic myelo-monocytic leukemia,慢性粒-单细胞白血病
, B! I' `- x* {8 @4 k- lCMPD:chronic myeloproliferative disease,慢性骨髓增生性疾病
% p0 I- b# U! k0 {1 R; J( X) P( y" pCMV:cytomegalovirus,巨细胞病毒6 f4 m5 [' K( z9 h
CNR:cytokine negative response cell,细胞因子不反应细胞4 n  f8 D# ^: ]% U7 [  ?
CNS:central nervous system,中枢神经系统
  n5 g8 b) J- T3 X6 zCNSL:central nervous system leukemia,中枢神经系统白血病
" \" W8 }  N& b; \- n6 uCollection: 采集2 G* O# N" k) ^
Colony stimulating factor:集落刺激因子
7 S, b# o- W; d/ n- d- M3 A( vc-onc:cellular oncogene,细胞癌基因
' n0 K( }. J* |; O5 zConditioning:预处理
& a# `" D+ w! SConjunctivitis:结膜炎; x3 Q) \) a$ B+ F: y: W9 K
Convalescence:恢复,恢复期
3 q; p* F- b) k5 \$ y. j4 x# CCP:cancer procoagulant,癌性促凝物质
. t' C0 F3 e, r! N* o' sCPD:citrate phosphate dextrose,枸橼酸盐-磷酸盐-葡萄糖/ d8 Q/ H- z* w% e
CPDA: citrate phosphate dextrose adenine,枸橼酸盐-磷酸盐-葡萄糖-腺嘌呤
/ V) B+ [5 g$ r) t5 o$ [Cpmax:peak concentration,峰浓度
1 S" ^8 g; t0 ^4 C* B0 f3 bCPT:camptothecine,喜树碱. i3 J3 ^9 |7 L) X/ r6 H, @9 u6 W; M
CR:complete remission,完全缓解
) ~8 v  u+ ?, [, F4 `CRABP:cytoplasmic retinoic acid binding protein,胞浆维甲酸结合蛋白
' X4 C0 P! C+ T+ v# K- OCRP:C reaction protein,丙反应蛋白 5 p- H7 o1 \: Q1 n
CRR:complete remission rate,完全缓解率
9 ~7 V+ C" m* R4 X5 ]" tCryopreservation:冷冻保存,深低温保藏
7 G' o3 @  \9 }  [2 m. t$ V2 a8 lCSF:colony stimulating factor,集落刺激因子
# g9 m+ e/ l% ?! K! S0 zCSF:cerebrospinal fluid,脑脊液" e' ?+ l* ]+ q  r  `
CTCL:cutaneous T cell lymphoma,皮肤T细胞淋巴瘤
3 z- o5 o9 Z( ~7 D( rCTCL:central T cell lymphoma,中枢T细胞淋巴瘤; V) R! n: I7 B2 r
CTL:cytotoxicity T lymphocyte,细胞毒性T淋巴细胞; y- E9 G1 O5 R# u: [/ p. L
Cyclin:周期素8 ^8 s* M$ D8 S
Cytomegalovirus:巨细胞病毒
6 y5 T5 K, q# KDC:dendric cell,树突细胞  ^: A; B3 e( q0 M; L! u
D-D:D dimer,D-二聚体( e8 v1 ?' q' f1 o3 E5 R) c' O3 ?
Del:deletion,缺失0 ^! N4 {% ]0 t5 B8 [) u. `
Dermatitis:皮炎 7 x$ r8 l6 h+ U
De nova AML:非继发性急性髓性白血病
6 @. ]4 L' \& w3 k; ?DFS:disease free survival,无病生存期
" Y/ q# d0 r6 T9 f, U7 J: oDI:DNA index,DNA 指数
/ N- m* I- q  \/ p$ jDIC:disseminated intravascular coagulation,播散性血管内凝血
$ l" E9 w/ e$ M  ]! Y' XDilution:稀释
2 l4 _' B1 a+ Z  D4 aDL:discordant lymphoma,混杂型淋巴瘤$ R; t6 J( k3 X) a. j
Donor:供者
" x7 E: i! i+ x/ O3 }+ sDysplasia:发育不良,发育异常 & A& u& H! _# T4 j: K4 H
EBV:Epstein-Barr virus,EB病毒, K2 r) h! Q* e" i( G, T) X/ R
ECM:extracellular matrix,细胞外基质
. {* M% g6 x8 d* a-ectomy:(后缀)(外科)切除,除去,去掉
2 O8 q4 g- U1 W+ U" K) l0 VEdema:水肿
; r& ?0 o" G7 ]EGF:epithelial growth factor,表皮生长因子
+ O) l" F8 h6 I( d-emia:(后缀)血液疾病 $ r' z" ~. p4 Q; ~- w
Encephalopathy:脑病
( b! c+ I4 B2 \! R5 X5 ?- D3 ?; OEncode: 编码$ ]  }8 T( @$ G: u; N
Engraftment:移植物植入 ! ]+ `0 S8 T; v' ~# P7 A7 t, [
Enrich:富集8 j. H# x( b; \6 |- A) O
Enzyme:酶 . U$ i# I# J- U' X
Eosinophil:嗜酸性粒细胞
  V1 w# x7 X* O6 R9 [EPO:erythropoietin,促红素,红细胞生成素7 n3 v/ r9 z+ E
ETT:essential thrombocythemia,原发性血小板增多症" |; ?( [( n" H$ k1 b4 K3 N
Ex vivo:体外
+ q4 j+ o3 L$ x5 h5 ^FACS:fluorescence activated cell sorting,荧光活化细胞分选系统% o4 m4 s) I3 @1 V
FCM:flow cytometry,流式细胞分析技术0 v5 d; N/ e  S, O% q
FDC:follicular dendritic cells,滤泡树突状细胞6 X+ @: R( @4 }" Z" A
FDGF:fibroblast derived growth factor,成纤维细胞源生长因子
* A/ E! C, M) W+ j5 R  QFebrile:发热的 $ S+ J3 S0 d& e
FFP:fresh frozen plasma,新鲜冰冻血浆
+ O; a# K# p" @% {% |FGF:fibroblast growth factor,成纤维细胞生长因子
; ]7 i3 u0 G/ XFHH:familial hemophagocytic histiocytosis,家族性嗜血组织细胞增生症) j0 B3 |! U0 P
FISH:fluorescence in situ hybridization,荧光原位杂交' m9 y! {5 E% V! k3 s8 w& |
FMF:familial Mediteranean fever,家族性地中海热9 \6 W; }0 q1 F" w, i
Foley catheter:弗利氏导尿管,气囊导尿管
& n+ Z6 c1 L/ Z: o2 b* }" rFrTBI:fractional total body irradiation,分次全身照射9 _% j- J% |5 U0 h
FSRC: 胎羊体内增殖的人造血干细胞
# I: i) c; W# ^6 A  j% n+ A0 iFungus:真菌 ( i! z: l0 B0 P( Z4 s
Fungi: Fungus复数形式  q( Q2 r4 l1 ~/ k( K/ d
G6PD:glucise-6-phosphate dehydrogenase,6-磷酸葡萄糖脱氢酶0 c  M2 s9 A% ^; E7 }4 M  }
Gastritis:胃炎
) X! q3 W, D5 ^# ]Gastrointestinal:胃肠道的
" v6 u, p2 p( O* VG-CFC:granulocyte colony forming cells,粒细胞集落形成细胞& E7 J6 A7 `6 ~- o$ c9 E
G-CSF:granulocyte colony stimulating factor,粒细胞集落刺激因子
) S$ Z2 O& l: x9 J+ [& S, wGCV:cytomegalovirus,巨细胞病毒5 W2 W. |, R% [( [' |* D, c
GCV:ganciclovir,更昔洛韦
$ H% z' H3 s) y% M/ tGI:gastrointestinal,胃肠道的. C" g& Q2 u4 m! D3 h3 Y3 s& G
GM-CSF:granulocyte-macrophage colony stimulating factor,粒-巨噬细胞集落刺激因子
7 I4 S7 G$ |5 o7 hGM-CFC:granulocyte-macrophage colony forming cells,粒-巨噬细胞集落形成细胞
4 V6 y3 s6 m& b7 m( H% M7 u' Y0 rGraft rejection:移植排斥(反应)
) V  A" `$ N' P9 `  w5 `Graft-versus-host disease:移植物抗宿主病 ( J4 E: r, W* P) j$ f6 R# l8 B
Granulocyte:粒细胞
: b5 Z9 S, n# |# xGrowth factor:生长因子
( [9 K7 q( b, H# a) hGTR:granulocyte turnover rate,粒细胞转换率5 t6 G, x/ R2 p* m4 l2 s( s, v/ g2 E  p
GVHD:graft-versus-host disease,移植物抗宿主病 5 C/ I* g, c, g6 P1 a" d
GVHR: graft-versus-host reaction,移植物抗宿主反应& j* N! f( L, S1 L
GVL:graft-versus-leukemia,移植物抗白血病
/ {, {* g" K0 ^4 k) E* LGVT:graft-versus-tumor,移植物抗肿瘤3 B7 Y/ D  f3 t: {; c  `( k* g
Haploidentical: 半相和的) b3 w' |3 z0 s5 M! ]) r
Harvest: 收集,采集8 l1 I/ B7 A1 I; p, Y$ o/ c0 u
HC:hemorrhagic cystitis,出血性膀胱炎; |: Z, k8 _" p, n* D( z2 `9 v: o( c
HCL:hairy cell leukemia,毛细胞白血病9 e# i! ?1 o3 a0 F/ D
HD:Hodgkin's disease,霍奇金病8 y4 \; [- `& u0 Q5 K# y2 B
HD:high dose,大剂量/ ^" N0 ?0 ]* D6 i
Hematocrit:红细胞压积 0 C) Y" n6 i2 V2 O5 F1 \# K
Hematology:血液学
# K0 _( a( G% ^) Z  ZHematopoiesis:造血作用,生血作用
3 F# z+ b3 C8 D& LHematopoietic system:造血系统: K( Y" c# f! ?6 X$ X
Hemoglobin:血色素,血红蛋白
( \; S( o! H  Q6 i; MHemorrhage:出血 9 c" d% a  S5 G. s% A
Hemorrhagic cystitis:出血性膀胱炎
& ]; ~: ~) `7 w( bHepat - :(前缀)肝的1 y! \/ L7 E* I$ r8 G! `
Hepatitis:肝炎
! ]# h+ ]1 H. p! Y8 r0 HHES:hypereosinophilic syndrome,高嗜酸粒细胞综合征
1 [1 A1 M" j  SHGF:hematopoietic growth factor,造血生长因子8 v* @3 W/ q5 z% I
HHV:human herpus virus,人疱疹病毒
, f# j( r6 R! sHickman catheter:Hichman导管,中心静脉插管
, A  K& b1 P+ x$ }/ PHIV:human immune deficiency virus,人免疫缺陷病毒+ c( o7 e5 Z/ I& n
HLA:human leukocyte antigen,人类白细胞抗原 ! u& k1 E4 |- W( D( f
HLH:hemophagocytic lymphohistiocytosis,嗜血细胞性淋巴组织细胞增生症4 f4 [  m" `# D1 M3 b6 d0 k
HMR:histiocytic medullary reticulosis,组织细胞性髓性网状细胞增生症4 G/ p0 Z8 n) S; |* B; B
Homogenic transplantation:同基因移植
5 Y: E! B# n5 E; z3 G. B% wHomozygote:纯合子
# ]" j9 ~# U5 G0 Z0 i" V: a) rHPC:hematopoietic progenitor cell,造血祖细胞/ Q+ ?: X( t' t8 P# J# q
HPP-CFU:high proliferative potential colony-forming unit,高增殖潜能集落形成单位7 q" V6 q$ f! f4 H# {2 b
HR-ALL:high risk ALL,高危型急性淋巴细胞白血病
4 r4 L# s  B& i8 e) s2 n% sHSC:Hand-Schuller-Christian disease,韩-薛-柯病
* r4 X, T, y) b* N  E* K! N0 G0 iHSC:hematopoietic stem cell,造血干细胞  J2 `' ^% o# V( d
HSR:homogenously staining region,均染色区
- W: N* U3 t% r: N: tHSV:herpes simplex virus,单纯疱疹病毒9 c" L  o( o: z. z) G% n' H3 r
HTC: typing cell,纯合子分型细胞
) F* g# D4 g6 `* _) l! F% L6 n  QHTLV:human T cell leukemia virus,人类T细胞白血病病毒
& K3 G+ r2 Q2 U) ^HVOD:hepatic venous occlusive disease,肝静脉闭塞病
* K) H  N% F1 i7 nHyper- :(前缀)高,超,(过)多  }8 E, x, M4 i5 f1 e
Hyperalimentation:高营养支持,静脉高营养" f7 _! e, {* B6 r: @
Hyperpigmentation:色素沉着过度
( g/ o% s  c$ t9 u+ o2 I) I! dHypertension:高血压 9 T5 B" g% U+ T. F1 Y& L6 i
Hypo- :(前缀)(过)低,少于
- p2 _0 n* p/ f2 `1 x; THypotension:低血压1 c4 F1 e9 D1 |3 I' T+ M
IAHS: infectous-associated hemophagocytic syndrome,感染相关嗜血细胞综合征/ F! T: m' T. m& ~& E: i
id:medium dose,中剂量2 A  K! e, N# j4 n3 @
id:initial dose,初始剂量6 N* i- R" F3 v& m) p# t
IF:involved field,累及野' ?$ X+ a3 Q5 J2 o; X0 n6 E
IFN:interferon,干扰素# l1 l, P9 y5 [% g$ S1 q+ v+ ^
Ig:immunoglobulin,免疫球蛋白 3 ~+ G' i+ {/ G- `# g2 [5 d$ y
IGFs: insulin-like growth factor,胰岛素样生长因子
3 e& z, r/ V( G" ~; KIgH:immunoglobulin heavy chain,免疫球蛋白重链
- S) O% B& p- n2 m4 Z( A% LIL:interleukin,白细胞介素
& o& n: _( J. pIliac crest:髂嵴 % `/ y6 h  m  V$ ?; z# W
I.M.:intramuscular,肌肉注射
8 j8 W8 D( }1 `8 j/ T# z3 S6 rImmune system:免疫系统
: j' ]- d. J  ], B& @* m7 N9 WImmunocompromised:免疫受损的 8 d0 ~/ ]9 W& Q) G4 N, l* J2 Z/ \; Z
Immunoglobulin:免疫球蛋白
( A- h( }, C3 e, iImmunological tolerance:免疫耐受
3 h# l  ~: {8 a* v( u) i% QImmunosuppression:免疫抑制 $ d) m5 k2 A' V6 H- ~' G: q
Incubation:孵育
" f* B, ^7 t9 ginformed-consent:知情同意) ]( z- f, n! Q! g1 `
Intravenous:静脉内的
* d8 W0 _6 [8 p" A* _0 W- t% ]inv: inversion,倒位
! C1 X, T! {2 g& B0 W$ {4 @2 Fin vitro: 体外,离体
  Y) t1 u8 K9 w: O/ v& @in vivo: 体内
# K" Y# b2 M2 o& g" I7 v+ PIP:interstitial pneumonia,间质性肺炎
+ R9 n% I) P# t7 i( e) \Isolation: 分离0 x5 T/ x* ~# a8 N
I.T.:intrathecal injection,鞘内注射) O7 Y1 t9 d) G9 Q; {" R
-itis:(后缀)炎症
, h4 x7 u- S, k: UITP:idiopathic thrombocytopenia purpura,特发性血小板减少性紫癜0 T% e- v, s2 \, x8 R
Jaundice:黄疸, [* r! J! g+ H5 E& D
KPS:Karnofsky score, Karnofsky评分' f2 v, ~+ L+ U5 C  Y5 @0 R
LAK:lymphokine-activated killer(cells),淋巴因子激活杀伤(细胞)
* q2 o6 ]3 y$ h! {$ gLaminar air flow unit:层流间
4 T5 p3 Q9 o& ?: B% j% W- Q% u( qLCH:Langerhans cell histiocytosis,郎格罕细胞(组织细胞)增生症7 W9 n5 \! W" g1 [0 Z% s' f
LD:lymphocyte depletion,淋巴细胞消减型6 c1 Z. t2 Q& r- U# ?, |, u& U
LD:low dose,小剂量/ _  b2 @( u- b" C" ~' g
LDH:lactate dehydrogenase,乳酸脱氢酶: O6 j/ d( q# {3 S
Leukapheresis: 白细胞采集物
: B" O8 p& Z' y5 r7 g7 N9 ]3 P/ {; X) DLeukemia:白血病 , t/ n3 I- X, l$ l
Leukocyte:白细胞
) N9 l8 H) f$ Y5 d9 O1 H' GLeukopenia: 白细胞减少症
0 D  j& m) l; _; W7 WLFA:lymphocyte function associated antigen,淋巴细胞功能相关抗原 - p* r# a: ?6 A
LFS:leukemia free survival,无白血病存活期
! i# o9 Z/ k' ULGL:low grade lymphoma,低度恶性淋巴瘤
: W+ p4 R+ L1 U9 k8 KLHR:lymphocytic homing function receptor, 淋巴细胞归家功能受体8 c' Y3 _7 e% |' Z; x  I# r0 `: E
LI:labeling index,标记指数
, n8 a6 `, ~6 N9 U  i) YLIF:leukemia inhibition factor,白血病抑制因子' r+ I  m0 c) f/ K& J
Lineage:系
# t8 w# E2 @( V( e: tLOH:loss of heterozygosity,杂合性丢失# e$ S* M( l7 T+ L
LP:lymphocyte predominance,淋巴细胞为主型
7 Y. K* F0 r. s: `LRP:lung resistance related protein,肺抗性相关蛋白
4 y  |) I2 q% t# w: v$ zLTB:life-threatening bleeding,致命性出血7 V" B! U6 c8 n4 t# u+ Y
LTC-IC:long-term culture-initiating cell,长期培养起始细胞
7 I6 E; m) v7 V3 gLTR:long terminal repeat:长末端重复序列
0 I6 Q* D& k0 d& VLVL:large volume leukapheresis,大容量白细胞单采* ?; @8 p- D4 d; v+ i+ q) G7 P+ D
Lymphocyte: 淋巴细胞3 I% ~/ X- U+ u1 t) H& U8 Q% g9 }
Macrophage:巨噬细胞
% s/ e5 t2 x3 j# ZMACS:magnetic activated cell sorting,磁性活化细胞分选. ~0 v) k$ {$ W& V; k/ M
MAK: monocytokine-activated killer(cells),单核细胞因子激活杀伤(细胞): W* P9 d% E  `2 h% p" n- c4 e! [; ^
Malabsorption:吸收障碍
, w- E& i) X1 R+ pMALT:mucosa-associated lymphoid tissue,粘膜相关淋巴样组织÷. C, a" i2 M, d& X. B0 K  U
Matching:配型% Z! m  E) L0 R+ T3 L
MBDI:marrow blast decline index骨髓原始细胞减少指数
7 q" n0 }; x" r, T: ^MC:mixed cellularity,混合细胞型4 E, @" n. L: K) l
McAb:monoclonal antibody,单克隆抗体1 U7 [1 h2 ?! @  Z8 @: Z' ~& X
mCR: median complete remission,中位完全缓解 2 o( X3 [' v2 x7 d! B: G, O: V
MDR:multiple drug resistance,多药耐药" G7 q( F; `$ e; J  Q
MDS:myelodysplastic syndrome,骨髓增生异常综合征& \) w+ ?6 e+ h6 Z
Megakaryocyte:巨核细胞
4 ]8 f. }* z  d/ ~2 g& d4 t% k! ~Metabolite:代谢物 6 `( H1 o) s, _0 u. D. H" b5 E
Metastatic:转移的 / d4 U; s! {  O) H
MF:myelofibrosis,骨髓纤维化8 {- W1 ^7 _& T) R
MF:mycosis fungoides,蕈样霉菌病3 z: {  ^4 w1 Z* i, `; K
MGDS:megakaryocyte growth and differentiation factor,巨核细胞增殖分化因子
: g2 g! g- n$ lMGP:marginal granulocyte pool,边缘粒细胞池& o2 t/ F1 G( P5 ?6 c: w
MGUS: monoclonal gammopathy of undetermined significance,未定性的单克隆γ球蛋白血症
; v9 Y; M' E, g) _& m+ x: @8 `MH:malignant histocytosis,恶性组织细胞增生症; d; E7 i0 S, O5 a# }
MHAS:minor histocompatibility antigen systems,次要组织相容性抗原系统
) c! N/ _' ^# Z6 ?. S- TMHC:major histocompatibility complex,主要组织相容性抗原复合体
$ {  `" Y$ T. x7 ]# `& HMLC:mixed lymphocyte culture,混合淋巴细胞培养 0 t7 j, U& F/ C! r$ ~+ Y
MLL:mixed lineage leukemia,混合系白血病
6 E+ S, H% `$ ~. @4 T' V: QMM:multiple myeloma,多发性骨髓瘤
  K- w) A! u! s8 v& P; @MNC:mononuclear cells,单个核细胞
8 B. W5 I: `, X; s2 ?9 o; d6 z6 ~Mobilization:动员
: ~4 E* \& r9 o. A, VMonoclonal antibody:单克隆抗体
0 Y$ W+ q) M# ?0 L4 [1 p1 z. fMonocyte:单核细胞
0 }/ U7 W7 u! S* A- A/ X& lMonozygotic:单合子的
! \$ O. N) q# c* c3 o/ T$ v; GMorbidity:发病率 + B& b9 p! T/ U; {5 X. \- x
MPD:myeloproliferative disease, 骨髓增殖性疾病
% s( A# y& n8 _+ m) yMPO:myeloperoxidase,髓过氧化物酶
9 C( b/ r8 V/ KMRD:minimal residual disease,微小残留病变
! P+ W7 L8 Q4 v8 {  qMRP:multidrug resistance-associated protein,多药耐药相关蛋白
( {$ K0 M6 f$ q# xMucositis:粘膜炎 ( u' G/ [# l, J1 M
MUD:matched unrelated donor,非血缘关系配型相合供体$ a6 ^# }* {, K5 p7 l: H- b$ ^- ]
NAP:neutrophil alkaline phosphatase,中性粒细胞碱性磷酸酶8 o8 j- E! y& J7 b
NB:neuroblastoma,神经母细胞瘤
, k4 ]( j; ^( J0 JNBM:normal bone marrow,正常骨髓& R# v6 q# A  X5 d( X# y! M' Q
Negative selection:阴性选择1 O' j4 Y% I7 E5 J$ A+ `
Neuro- :(前缀)神经的
- t3 @$ E- s1 c- qNeutropenia:中性粒细胞减少症
  H- F1 t! r! g0 a% uNeutrophil:中性粒细胞 5 [, Q' A& I: I: C7 k/ T- L
NG:neutrophil granulocyte,中性粒细胞
- q9 N) K! Q' P* j6 m7 [+ K) P7 wNGF:nerve growth factor, 神经生长因子
7 G* N, w& ]: p( y) Z4 X2 ANHL:non-Hodgkin's lymphoma,非霍奇金淋巴瘤1 M' Y0 m0 f7 ~& b6 O( O* t
NK: nature killer cell,自然杀伤细胞
* c! \4 v1 l; l7 gNonmyeloablative transplantation: 非清髓性移植7 N2 z% Q; ~: G4 s
NPO:不能进食 $ _; e9 Y3 L. Z5 L. T6 A. T
NS:nodular sclerosis,结节硬化型 8 E! E( f1 o+ ]) U; x: ^! D3 M
Oncology:肿瘤学 3 e: C9 t4 m2 A" G3 Y
Oto- :(前缀)耳的9 R# ^( X4 x  M+ f5 h7 L
PA:plasminogen activator,纤溶酶原激活物0 N) A+ k4 A1 Y, e2 o7 J+ o, `
Packed red blood cells: 压积红细胞 7 n9 N* v! |" H1 v. ^5 M' B* u
PAE:post antibiotic effects,抗生素后续作用
& S' F, i9 R* E/ r# j) [PAI:plasminogen activator inhibitor,纤溶酶原激活物抑制剂
( u" Q9 x( H' Z& gPalliative:减轻的,缓解的
9 ?# S0 S# }7 ]+ V& G" C7 t+ C) J7 Spalliative care unit (PCU):终末期病房,临终关怀病房
) F" C4 A1 o$ h, i2 GPancytopenia:全血细胞减少症 ! f* e# O7 e/ ?2 k  E  H
-pathy:(后缀)病
, {+ y, j- W6 V' K7 b4 sPB:peripheral blood, 外周血$ h! ]7 D3 b) T5 l" k
PBL:peripheral blood lymphocyte,外周血淋巴细胞
4 F7 N- G' n1 ?& SPBPC:peripheral blood progenitor cell,外周血祖细胞5 o8 I5 B; C0 [! n3 |
PBSCT:peripheral blood stem cell transplantation,外周血干细胞移植
% w9 {; N% \& S+ W9 s; b* }/ [  JPCA:procoagulant activity,促凝活性物质
" X; n" ~% ~3 Y2 l6 C# ePCD:programmed cell death,细胞程序化死亡
: u( T9 q  a6 v3 aPCL:plasma cell leukemia,浆细胞白血病2 w1 ~: I8 f& }* f/ o
PCLI:plasma cell label index,浆细胞标记指数! b7 L( T7 F9 D; K% g/ @1 `; h
PCR:polymerase chain reaction, 多聚酶链反应
; ]0 j* T9 W) s3 C0 ~4 qPCR-RFLP: PCR-restriction fragment length polymorphisms,限制性片段长度多态性分析# W. L& s; k% I1 G0 ~) m2 m: d2 x/ I
PCR-SSOPH: PCR-sequence specific oligonucleotideprobe hybridization,序列特异性寡核苷酸探针杂交
$ t: @5 q1 u9 F5 X- I: x# lPDD:percentage depth dosage,百分深度剂量. S0 H& Y4 a9 K) G# {( [% n
PDGF:platelet derived growth factor,血小板衍生生长因子
  T8 z: s( y- }5 QPDR:primary drug resistance,原药耐药( |, c  y+ D& @. w: j4 R- J
PE:plasma exchange,血浆置换9 A  u/ @! `2 C/ E2 w
-penia:(后缀)缺乏,不足
, B4 o! b1 H. D% `/ a  Y5 t# DPeripheral neuropathy:周围神经病变 / W4 K2 L+ G* L! z+ {( s/ u
Petechiae:瘀点,瘀斑
) b9 d7 q$ b+ IPfu: plaque forming unit,空斑形成单位
& ^$ l* s0 f5 uPHA:phytahematoagglutinin,植物血凝素
: L, q7 R' j$ q: t, u( O/ K% @+ |Phlebitis:静脉炎 2 I- ^( b: e; D4 H
PHSC:pluripotential hematopoietic stem cell,多能造血干细胞
, ~# F" {; e; d7 ~-plasia:(后缀)发展,形成 ! n4 O4 J' J4 \. p
Plasma:血浆
' x* D+ a* j$ d$ f' v* s# vPlasma cell: 浆细胞
7 M6 g. e7 h3 P- K8 BPlatelet:血小板
( s$ W- j' c7 j( BPLG:plasminogen,纤溶酶原, V- i6 ]/ C2 k- s9 B! O+ Z
PLL:prolymphocytic leukemia,幼淋巴细胞白血病
7 x( ~, X' V) s( k6 y2 [/ s& ?3 jPLT:platelet,血小板
1 i: |' C1 \3 C8 pPLT:primed lymphocyte test,预致敏淋巴细胞试验+ a" X9 e/ L1 `, q) a, r( V$ ^. m1 M
PMN:polymorphonuclear leukocyte,多形核白细胞1 x7 k0 T; O  g
PNH:paroxysmal nocturnal hemoglobinuria,阵发性睡眠性血红蛋白尿÷
: D; g7 D# l0 r4 WPNRE:p53 negative response element,p53阴性反应元件, u: j6 n) l3 O7 C
POD:PML oncogenic domain,PML癌基因结构域1 f  y' ^. e: s6 U3 J
Polycythemia:红细胞增多症 0 D4 C  ?- d+ {2 U( R% V% W
Positive selection:阳性选择% D7 X9 `/ B% r% D9 ~
PPSC: pluripotent hemotopoietic stem cell,全能造血干细胞; `+ |" W' k: D, l$ V
Preparative regimen:预处理方案 , B, \* @- G: o
Progenitor:前体,祖先  M: F/ o+ K) v' p1 D
Prognosis:预后
. u, y: B/ g) RProphylactic:adj.预防的;n. 预防性,预防药! D. g1 B& a/ ^
Prophylaxis:预防法,预防
/ Y. i- V6 o1 HProtocol:草案,协议,治疗方案
2 S9 B8 L, c0 k1 GProto-onc: proto-oncogene,原癌基因
) f, L! |1 L3 N. J7 [PSS:posterior superior spine,髂后上棘
8 Q6 d. u# u, f- }PT:prothrombin time,凝血酶原时间! ?; [5 T1 u" Q1 N2 C% Q
PTCL:peripheral T celll lymphoma,外周T细胞型淋巴瘤# u: D) v  R, j& i( P
PTH:post-transfusion hepatitis, 输血后肝炎
: E, Z# X) }- h# }! b) P2 gPulmonary:肺的
+ ^" }" X& d$ K7 K% }Purging:净化
4 |4 j; V! u. C* I: CPurity:纯度6 }& e% ]  r  \; r8 o
PV:polycythemia vera,真性红细胞增多症
$ X# y9 L: P1 {: O0 `Quality of Life (QOL):生活质量5 m2 Q- N! |/ m$ M
RA:refractory anemia,难治性贫血 1 j: T+ Q3 Q& c" k! j& m
RAEB:refractory anemia with excessive blasts,难治性贫血伴原始细胞增多型& b# ]2 C. i$ I
RAEB-T:refractory anemia with excessive blasts,transformation,难治性贫血伴原始细胞增多转化型
  r3 u4 N8 {+ d3 }RAR:retinoic acid receptor,维甲酸受体* y' j! Z$ ]4 {# g' Y
RAS:refractory anemia with sideroblasts,难治性贫血伴环状铁粒幼细胞增多
1 B& f0 X2 ]6 K8 g1 ARAS:retinoic acid syndrome,维甲酸综合征
* }, l" j( l  p2 z, KRB:retinoblastoma,视网膜母细胞瘤
" ~/ w8 d( h$ J( V9 g5 @RBC: red blood cell,红细胞 - d) r! Q/ x9 I" f' t" H( ^/ M
Reagent:试剂
/ u/ x/ Y) n) [9 {Recipient:受者
. C4 U3 d+ K  o  O5 D, DRejection:排斥, t) E; X! d/ D" H
Relapse:复发
. h8 P2 H" H* ~; f8 D1 z; ORemission:缓解 - f9 O9 M# \, d! A8 v* ]9 E$ Y& |, v0 l
Renal:肾脏的,肾的 ; I4 T# }9 t+ e" b; G% y# p
RFS:replase free survival,无复发生存5 q9 u2 L0 \0 {% F! o. C' E# F$ N
RPC:radiation protective competence, 辐射保护能力
/ x) b8 A* i' i- wRegimen-related toxicity (RRT):预处理相关毒性
0 c4 \& Z0 i2 u- H) |RT-PCR:reverse transcription polymerase chain reaction, 逆转录多聚酶链反应
# e3 ^$ |8 U, sSBB:sudan black B,苏丹黑B
8 T1 @  [6 ?5 dSCE:sister chromatial exchange,姐妹染色单体交换
( }& m$ X8 C' }) oSCF:stem cell factor,干细胞因子
2 u% {6 E9 C: ]0 t; C; GSCid:severe combined immunodeficiency disease,重症联合免疫缺陷
! r# s) `; z4 o1 O: lSCL:stem cell leukemia,干细胞白血病
) c3 j+ I4 P5 nSE:specific estarase,特异性酯酶
, u( p$ ~7 @0 [# M) ySelectin:选择素0 {  ]+ d0 I, A7 I$ p& A1 [& P
Sense primer:同义引物. R  v6 V5 l" Y; @& v
Separation:(细胞)分选% z- P4 m4 U; m+ u$ c8 O3 C/ \2 D
Sepsis:脓血病,败血病
* X6 x% S- h6 iSequencing测序/ a) l' A3 o8 u# ^
SF:serum ferritin,血清铁蛋白
" I" d  Y7 l5 ISHML:sinus histocytosis with massive lymphadenopathy,窦性组织细胞增生症伴块状淋巴结肿大# a/ a* K8 E0 z7 d% \
SIA:stroma-support immunocytometric assay,基质支持免疫细胞流式细胞仪技术法
, W4 |  ?. ^* U( W/ N! `& rSLE:systemic lupus erythematosus,系统性红斑狼疮
  M* \( Z$ }: [0 I; @SLL:small lymphocytic lymphoma,小淋巴细胞淋巴瘤! T; L+ N' M  G8 z$ s/ j' Q+ f6 O
Solid tumor:实体瘤
5 O" `4 E& o1 ~- k# W7 h( Z$ j7 bSR-ALL:standard risk acute lymphocytic leukemia,标危型急性淋巴细胞白血病( `1 R9 ]3 S' \& r+ X$ W4 A6 t0 E+ {8 p
SRC:SCid/NOD小鼠体内增殖的人造血干细胞,SCid造血重建细胞
# k- O0 ^! [0 uSS:Sezary syndrome,Sezary综合征
) l# \/ G; R. d' }4 z0 U* yStem cell:干细胞' A5 E  w" Z1 @1 j. S# i
STNI:subtotal nodal irradiation,次全淋巴结照射
( w: ?$ I" q/ \4 {Stomatitis:口炎
$ O5 P$ v% W4 a0 fSubclavian catheter:锁骨下导管
7 X7 l1 M' f" l) i/ _Supernatant:上清
% Q' q+ m* i; m* e( k1 X# XSyn-BMT:Syngeneic bone marrow transplant:同基因骨髓移植
; H, l' v4 O, S% i0 S% _Syngeneic:同基因的
0 ?  {# S; B" tTAM:tumor associated macrophage,肿瘤相关巨噬细胞
3 Q3 z* u. X5 q9 Ut-AML:treatment associated AML,治疗相关的急性髓性白血病
( h4 w. @3 T+ sTA-GVHD:transfusion associated graft-versus-host disease,输血相关的移植物抗宿主病) r7 K& A. ~- b# u3 I( S/ O6 C
TAA:tumor associated antigen,肿瘤相关抗原5 J8 D7 p$ n- c0 B
TBGP:total blood granulocyte pool,总血液粒细胞池4 Q$ P2 s, @% t4 H  d9 ?
TBI:total body irradiation,全身照射7 ?* \# E7 d8 e# B
Tc:time of cell cycle, 细胞周期时间& h/ F8 i+ B6 ]! ?% s3 c
TCD:T cell depletion, T细胞去除, {0 Q7 g* n( f% }4 B
TCL:T cell leukemia/lymphoma,T细胞白血病/淋巴瘤
7 a; C( ?( |2 ~8 v: K  u0 y. ^2 W! LTCR:T cell receptor,T细胞受体5 O: i$ z8 b; C0 q
TCS:tumor cell survival,肿瘤细胞成活0 v2 [; B- u2 a# x$ [
TEN:total enteral nutrition,完全胃肠内营养9 R: ^! ]" h; S1 K
TF:tissue factor,组织因子
8 y& i3 Z1 \9 o" Y, k4 u3 B" c, _4 ITF:thymic factor,胸腺因子
; \+ s6 [# V+ @TFPI:tissue factor pathway inhibitor,组织因子途径抑制物, {8 ]+ \" q) f/ s+ k6 V
TGF:therapeutic gain factor,治疗获得系数8 j5 A- \$ q4 z4 m; D! F
TGF-β:transforming growth factor-β,转化生长因子β
; C* }: r5 [6 d- m/ @1 nThrombocyte:血小板
+ w; ^  \1 z( `& A$ R: I6 o. T# s2 f* ]Thrombocytopenia:血小板减少症
$ q* ]7 H$ m4 Q* tTIL:tumor infiltrate lymphocyte,肿瘤浸润淋巴细胞# ~7 z. C4 y, R/ d# A
TL:testis leukemia睾丸白血病
8 n$ A1 s3 E7 d5 q& n) ]. BTLI:total Lymphoid irradiation,全淋巴照射
- [! Z0 E. U" f+ Q) k5 MThrombotic microangiopathy (TMA):血栓性微血管病* I6 J' E5 \9 }) T
TNF:tumor necrosis factor,肿瘤坏死因子
- D) C/ P. i9 h$ C+ v  ]TNI:total nodal irradiation,全淋巴结照射% o4 p4 v! \% M$ t, E
TOPO II:topoisomerase II,拓扑易构酶II
* B; m( u, j9 t6 O% r8 w* TToxin:毒素 . ?6 s; W8 z- x, n: y' w, H
Tpdt:potential doubling time,倍增时间
/ N  V) Z4 k2 O6 c; `T-PLL:T-prolymphocytic leukemia,T幼淋细胞白血病0 W9 r2 a7 _3 A+ Y* I. u5 Z
TPN:total parenteral nutrition,全肠道外营养,静脉高营养
6 g) U  \8 K' l& u7 U$ qTPO:thrombopoietin,促血小板生成素. N' [9 l0 g( a7 W- N
TPS:treatment planning system,治疗计划系统
3 w& O/ A4 g! S& |1 @2 q- XTranslocation:易位: Z/ e) d3 @$ q$ D7 I
Trauma:创伤
; X0 B7 D5 D# y2 eTRM:transplantation related mortality,移植相关死亡率5 m% ]! l# o: R& I9 Z4 c
TSC:timed-sequential chemotherapy,时相序贯化疗6 S$ T* _: ]0 @9 j8 p
TSPA:triophosphoramide,噻替派
5 [3 c- a- T& FTTP:thrombotic thrombocytopenic purpura,血栓性血小板减少性紫癜
5 X, T& P; g" q- F7 D9 LTumor:肿瘤
6 g3 F2 |$ v; H- x3 E- JTumor burden:肿瘤负荷 : X8 a* C6 i9 r2 u
UCB:umbilical cord blood,脐带血
- C4 b4 M7 L1 X6 Z3 p$ a5 kUltrasound:超声
& p8 S/ |( Z% w8 z' h8 aUmbilical cord:脐带, i, B3 w0 ~+ r9 z& [
VAHS:viral associated hemophagocytic syndrome,病毒相关嗜血细胞综合征
/ ~+ [" v* ^8 Y7 |VGPR:very good partial remission,非常良好的部分缓解
  A; u* m; R0 z* @" t# h- i( _7 XViability:活性# O) l) m( ^( V$ T' l( k& L
Virus:病毒
+ t' m  x0 j! a+ QVOD:veno-occlusive disease,静脉阻塞性疾病 ( [6 m, S/ @* D7 |; Z- W5 a# A! u
v-onc: virus oncogene,病毒癌基因% Y( z7 b. L8 N9 M' i
VPF: vascular permeability factor,血管渗透因子# Z4 i! [7 A& s7 W
VZV:varicella zoster virus,水痘带状疱疹病毒
7 D* d7 M+ z* o: L' L9 jWBC:white blood cell,白细胞 # g+ F5 H% \  u5 U: |& l
Whole blood:全血 # O- ?8 r1 S! a7 O: w
WT:Wilms tumor,肾母细胞瘤
$ h+ N% _3 w: f5 M: ?Xerostomia:口腔干燥症 7 h( K! {0 i# r" ]+ A- E4 Y  g
Yield:产量




欢迎光临 干细胞之家 - 中国干细胞行业门户第一站 (http://www.stemcell8.cn/) Powered by Discuz! X1.5